A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)

Summary

The purpose of this study is to determine the safety and tolerability of RNS60 in patients with Amyotrophic lateral sclerosis (ALS). Investigators will also measure the impact of RNS60 on several markers of neuro-inflammation, measured by blood biomarkers and positron emission tomography (PET) imaging.

Timeline

Start

2015-10

Primary completion

2017-06-21

Completion

2017-10-18

Drugs

Indications